openPR Logo
Press release

Global Filgrastim Market - With Future Growth By Top Players Cadila Pharmaceuticals Ltd, Abbott Laboratories Inc., Dr. Reddy's Laboratories Inc, Intas Biopharmaceuticals Ltd, Amgen Inc.

10-09-2018 11:21 AM CET | Health & Medicine

Press release from: Allied Market Research

Filgrastim Market

Filgrastim Market

The newest research report Global Filgrastim Market illustrates pin point sharp market insights includes detailed Filgrastim industry aspects forecast over a period from 2018 to 2025. It conducts a fervent study of business positions to offer in detail knowledge of Filgrastim business habits of past, present, and future.

Increase in prevalence of various diseases and surge in geriatric population drives the market growth. Moreover, increase in pressure to decrease healthcare expenditure and surge in demand for filgrastim due to its cost effectiveness is anticipated to boost the growth of this market. However, dearth of trained healthcare professionals and accuracy of devices impede the market growth.

Get Sample Copy of this Report: https://www.alliedmarketresearch.com/request-toc-and-sample/3643

Comprehensive competitive analysis and profiles of major market players such as
• Cadila Pharmaceuticals Ltd
• Abbott Laboratories Inc.
• Dr. Reddy's Laboratories Inc
• Intas Biopharmaceuticals Ltd
• Amgen Inc.,
• Emcure Pharmaceuticals Ltd
• Reliance Life Sciences Pvt. Ltd
• Novartis AG
• Sandoz Inc
• Biocon Ltd.

Filgrastim is a granulocyte colony-stimulating factor in humans and a hematopoietic agent utilized for prevention of infection and neutropenic (low count of WBCs) fevers triggered by chemotherapy, HIV/AIDS, radiation poisoning, or others. Filgrastim can be administered by subcutaneous injection or infused into vein by IV.

The global filgrastim market is segmented on the basis of type of manufacturing, application, and geography. Based on type of manufacturing, it is bifurcated into in-house manufacturing and contract manufacturing organizations. Based on application the market is divided into oncology, chronic and autoimmune diseases, blood disorders, growth hormone deficiency, infectious diseases, and others. By geography, it is analyzed across North America, Europe, Asia Pacific, and LAMEA.

Make Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/3643

Key Benefits

• The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
• Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework
• It offers a quantitative analysis from 2017 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

Access the latest trends and insights: https://www.alliedmarketresearch.com/filgrastim-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Filgrastim Market - With Future Growth By Top Players Cadila Pharmaceuticals Ltd, Abbott Laboratories Inc., Dr. Reddy's Laboratories Inc, Intas Biopharmaceuticals Ltd, Amgen Inc. here

News-ID: 1290082 • Views:

More Releases from Allied Market Research

Brown Grease Market In U.S. Size | Industry Thriving Worldwide at a Significant Growth | Forecast to 2032
Brown Grease Market In U.S. Size | Industry Thriving Worldwide at a Significant …
Allied Market Research published a new report, titled, U.S. Brown Greas Market " The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. The
Vietnam PET preforms Market Top Companies and Regional Average Pricing Analysis …
Allied Market Research published a new report, titled, " Vietnam PET Preforms Market." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. The report
Oleochemicals Market Leading Global Top Companies and Regional Average Pricing Analysis by 2032
Oleochemicals Market Leading Global Top Companies and Regional Average Pricing A …
Allied Market Research published a report, titled, "Oleochemicals Market by Type (Fatty Acid, Fatty Alcohol, Glycerol, and Others) and Application (Pharmaceuticals, Personal Care & Cosmetics, Food & Beverages, Soap & Detergents, Polymers, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the global Oleochemicals market was valued at $29.9 billion in 2022 and is projected to reach $55.2 billion by 2032, expanding at a CAGR of
Smart Glass Market Size is Anticipated to Grow $15.1 Billion by 2030 | Growing at a CAGR of 12.6%
Smart Glass Market Size is Anticipated to Grow $15.1 Billion by 2030 | Growing a …
Allied Market Research published a report, "Smart Glass Market by Technology (Thermochromic, Photochromic, Electrochromic, Suspended Particle Device (SPD), Polymer Disperse Liquid Crystal (PDLC), and Others), and End user Industry (Transportation, Construction, Power Generation, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030". As per the report, the global smart glass industry is expected to reach $15.1 billion by 2030. The market accounted for $4.62 billion in 2020 and is predicted

All 5 Releases


More Releases for Filgrastim

Filgrastim Biosimilar Insight report on 20+ companies and 20+ marketed and pipel …
(Albany, US) Filgrastim Biosimilar Insight report on 20+ companies and 20+ marketed and pipeline drugs | DelveInsight "Filgrastim Biosimilar Insight, 2022" by DelveInsight covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products with Global coverage. It also includes the therapeutics assessment by product type, stage, route of administration, and molecule type. It further showcases the inactive pipeline products in this space. Filgrastim Biosimilar Report Highlights • The companies and
Filgrastim Biosimilars Market 2022-2031 | Industry Overview, Estimated Growth, C …
Filgrastim Biosimilars Global Market Report 2022 - Market Size, Trends, And Global Forecast 2022-2026 by The Business Research Company is the most comprehensive report available on this market, with analysis of the market's historic and forecast growth, drivers and restraints causing it, and highlights of the opportunities that companies in the industry can take on. The filgrastim biosimilars market research report helps gain a truly global perspective of the filgrastim
Filgrastim Biosimilars Market Forecast 2021-2030 | Key Markets and Segment Perfo …
Get up to 33% off on ALL market research reports at The Business Research Company's holiday sale; buy now! https://www.thebusinessresearchcompany.com/global-market-reports ‘Filgrastim Biosimilars Global Market Report 2021 – COVID-19 Growth And Change’ by The Business Research Company is the most comprehensive report available on this market, with analysis of the market’s historic and forecast growth, drivers and restraints causing this, and highlights of the opportunities that companies in the industry can take
Filgrastim Market Strategic Assessment, Growth Analysis and Research Outlook 202 …
Latest research on Filgrastim Market report covers forecast and analysis on a worldwide, regional and country level. The study provides historical information of 2015-2021 together with a forecast from 2021 to 2027 supported by both volume and revenue (USD million). The entire study covers the key drivers and restraints for the Filgrastim market. This report included a special section on the Impact of COVID19. Also, Filgrastim Market (By major Key
Filgrastim Biosimilars Market Segmentation, Regional Analysis And Growth: Biocon …
The global filgrastim biosimilars market reached a value of nearly $785.33 million in 2019, having increased at a compound annual growth rate (CAGR) of 12.13% since 2015. The market is expected to grow from $785.33 million in 2019 to $860.12 million in 2023 at a rate of 2.30%. The market is expected to grow from $860.12 million in 2023 to $984.23 million in 2025 at a CAGR of 6.97%.
Filgrastim Market Professional Analysis Report 2019| Amgen, SANDOZ INC, Teva
The report on the global Filgrastim market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that players could improve their sales and growth in the Global Filgrastim Market. It offers a detailed analysis of the competition and leading companies of the global Filgrastim market. Here, it